Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
1 other identifier
observational
351
1 country
1
Brief Summary
Individuals with tic disorders have lower quality of life, sensory and movement difficulties, and poorer mental, social, and physical health compared to the general population. Current clinical care for individuals with tic disorders is limited: no interventions are proven to prevent or stop the disorder exist, and most treatments focus solely on tics, though other symptoms often affect quality of life more than tics. To develop new treatments and improve care for people with tics, researchers need to better understand the different symptoms people experience and how the brain causes these symptoms. Many individuals with tic disorders have sensory and movement symptoms other than tics. A common sensory symptom is increased sensitivity to common sensations, such as glare from sunlight, tags in shirt collars, and noises from passing cars. A common movement symptom is poor handwriting and/or poor coordination. In one study of adolescents with tic disorder, difficulty with hand coordination predicted tic severity 7.5 years later, suggesting that sensory and/or motor difficulties may be a risk factor for more severe tics later in life. Despite how common they are, much is unknown about sensory and motor difficulties experienced by people with tic disorders. Additionally, most studies of people with tics enroll younger children. As a result, little is known about sensory, motor, and psychosocial development in adolescents with tics. Knowledge of sensory and motor difficulties in adolescents with tics is important to understand because, in other adolescent populations, such difficulties are associated with worse mental and social health and worse quality of life. Deepening insight into the sensory, motor, and psychosocial development of adolescents with tic disorders is crucial to identify causes and risk factors for poor health in this population. The goals of this study are to measure sensory and motor symptoms and function in adolescents with tics and to compare them to adolescents without tics. The research team will enroll adolescents with tics and adolescents without tics to participate in the study. Adolescent participants will complete questionnaires, electroencephalogram (EEG) tasks, and other sensory and motor tasks at baseline (with 2 study visits occurring within 30 days of each other) and 2 years later (again, with 2 study visits, occurring within 30 days of each other). A parent or other adult who knows the adolescent well will also complete questionnaires as part of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedStudy Start
First participant enrolled
October 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2030
November 24, 2025
November 1, 2025
4.8 years
August 26, 2024
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Adolescent/Adult Sensory Profile (AASP)
validated, 60-item self-report questionnaire assessing sensory experiences
from baseline to 2-year follow-up
Sensory Perception Quotient
35-item self-report questionnaire assessing self-perceived basic sensory sensitivity
from baseline to 2-year follow-up
Sensory Gating Inventory
validated, 36-item self-report questionnaire assessing sensory over-responsivity
from baseline to 2-year follow-up
Adolescent Motor Competence Questionnaire (AMCQ)
validated, 26-item self-report questionnaire assessing self-perceived coordination
from baseline to 2-year follow-up
Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2)
validated, rater-administered scale assessing motor coordination
from baseline to 2-year follow-up
Purdue pegboard
validated, rater-administered task assessing manual dexterity and coordination
from baseline to 2-year follow-up
Vibrotactile battery, with BrainGauge (CM4)
Device- and rater-administered battery assessing several features of vibrotactile threshold perception, including static threshold detection, dynamic threshold detection, amplitude discrimination without and with adaptation, sequential and simultaneous frequency discrimination
from baseline to 2-year follow-up
Tactile gating indices
Participants will undergo a tactile gating paradigm, while monitored on electroencephalogram (EEG), during which puffs of air will be administered to the index finger.
from baseline to 2-year follow-up
Contingent negative variation indices
Participants will undergo a contingent negative variation paradigm, while monitored on electroencephalogram (EEG), during which puffs of air will be administered to the index finger, cueing the participant to respond
from baseline to 2-year follow-up
Secondary Outcomes (33)
Yale Global Tic Severity Scale (YGTSS)
from baseline to 2-year follow-up
Premonitory Urge for Tics Scale (PUTS)
from baseline to 2-year follow-up
Adult ADHD Self-Report Scale for DSM-V (ASRS-V)
from baseline to 2-year follow-up
Obsessive-Compulsive Inventory-Child Version-Revised (OCI-CV-R)
from baseline to 2-year follow-up
PROMIS Pediatric SF GenPop v3.0 - Anxiety 8a
from baseline to 2-year follow-up
- +28 more secondary outcomes
Other Outcomes (8)
Edinburgh Handedness Inventory - Short Version
from baseline to 2-year follow-up
Pubertal Development Scale
from baseline to 2-year follow-up
Weschler Abbreviated Scale of Intelligence, 2nd edition (WASI-II), 2-subtest with Vocabulary and Matrix Reasoning
baseline
- +5 more other outcomes
Study Arms (2)
adolescents with tic disorder
neurotypical adolescents (controls)
Interventions
This study involves no intervention.
Eligibility Criteria
Participants must be willing to attend Visits 2 and 4 in-person
You may qualify if:
- adolescent age 11-17 years of age
- adolescent diagnosis of chronic tic disorder (Tourette syndrome, chronic motor tic disorder, chronic vocal tic disorder)
- English-speaking adolescent and caregiver/adult proxy (as validated questionnaires are in English)
- adolescent and caregiver/adult proxy willingness and ability to complete relevant questionnaires
You may not qualify if:
- cognitive or attentional impairment precluding ability of adolescent or caregiver/adult proxy to complete questionnaires and other study measures
- adolescent diagnosis of autism spectrum disorder (ASD) or psychotic disorder
- adolescent diagnosis of pervasive genetic disorder besides chronic tic disorders and their known comorbidities
- adolescent with severe medical conditions unrelated to chronic tic disorders (e.g. uncontrolled seizures, prominent heart conditions)
- other variables that might influence ratings outside of the typical presentation of chronic tic disorders
- adolescent treatment with stimulant medications or anti-seizure medications within the past 30 days
- use of marijuana or recreational substances within the past 30 days
- history of seizure
- history of hearing loss or abnormalities
- history of neuropathy or overt sensory deficit
- history of brain surgery or skull-penetrating/deforming trauma
- history of stroke, brain cancer, or other significant neurologic illness/disorder \*\* Individuals excluded based on these criteria are ineligible for the EEG portion of the study but can complete the remainder of the study measures.
- adolescent age 11-17 years of age
- English-speaking adolescent and caregiver/adult proxy (as validated questionnaires are in English)
- adolescent and caregiver/adult proxy willingness and ability to complete relevant questionnaires
- +14 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashvile, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Isaacs, MD, MPH
Vanderbilt University Medical Center
Central Study Contacts
Michelle Clinical Translational Research Coordinator II
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology and Pediatrics
Study Record Dates
First Submitted
August 26, 2024
First Posted
August 29, 2024
Study Start
October 24, 2024
Primary Completion (Estimated)
August 1, 2029
Study Completion (Estimated)
May 1, 2030
Last Updated
November 24, 2025
Record last verified: 2025-11